written on 20.06.2014
Tags:
,

FDA moves for more warnings on testosterone products

TAGS: ,

The FDA has dealt a blow to the $1.6 billion testosterone supplement market, which includes the top-selling AndroGel, made by AbbVie. The drug labels must now include a general warning about the risk of blood clots in veins.

Latest Report